Therapeutic Asset Ratings
12,939 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
prt2527
Myelodysplastic/Myeloproliferative Neoplasm
Prelude Therapeutics
P1
CC
(47)
prt2527
Myelodysplastic Syndrome
Prelude Therapeutics
P1
CC
(47)
prt2527
Myeloid Neoplasm
Prelude Therapeutics
P1
CC
(47)
prt2527
Richter Transformation
Prelude Therapeutics
P1
CC
(47)
prt3645
Malignant Mesothelioma
Prelude Therapeutics
P1
CC
(47)
prt3645
Non-Small Cell Lung Carcinoma
Prelude Therapeutics
P1
CC
(47)
Prv-002
Traumatic Brain Injury
Odyssey Group International, Inc.
P1
CC
(47)
(+)-QUINIDINE
Liver Disorder
AstraZeneca
P1
CC
(47)
RECOMBINANT HUMANISED IgG1 KAPPA ANTI-CLDN1 MONOCLONAL ANTIBODY ALE.F02
Fibrotic Liver Disease
Alentis Therapeutics AG
P1
CC
(47)
Recombinant Human Serum Albumin
Hepatic Ascites
Protgen Ltd
P1
CC
(47)
REPAGLINIDE
Healthy Adult Participants
Institut de Recherches Internationales Servier (I.R.I.S.)
P1
CC
(47)
Repotrectinib
Liver Disorder
Bristol-Myers Squibb
P1
CC
(47)
Ribociclib
Male Breast Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
P1
CC
(47)
ro7303509
Systemic Sclerosis
Genentech, Inc.
P1
CC
(47)
Rosuvastatin
Focal Cortical Dysplasia
GRIN Therapeutics, Inc.
P1
CC
(47)
Rosuvastatin
Healthy Adult Participants
Institut de Recherches Internationales Servier (I.R.I.S.)
P1
CC
(47)
Rosuvastatin
Healthy Volunteers Sickle Cell Disease, Thalassemia
Novo Nordisk A/S
P1
CC
(47)
Rosuvastatin
Other Neurological Disorders
GRIN Therapeutics, Inc.
P1
CC
(47)
rp12146
Ovarian Cancer
Rhizen Pharmaceuticals SA
P1
CC
(47)
Saroglitazar
Liver Disorder
Zydus Therapeutics Inc.
P1
CC
(47)
sb-497115-gr
Healthy Adults
Mirati Therapeutics Inc.
P1
CC
(47)
Selinexor
Acute Lymphoblastic Leukemia
St. Jude Children's Research Hospital
P1
CC
(47)
Selinexor
Mixed Phenotype Acute Leukemia
St. Jude Children's Research Hospital
P1
CC
(47)
shr7280
Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.
P1
CC
(47)
snk02
Refractory Malignant Neoplasm
NKGen Biotech, Inc.
P1
CC
(47)
Showing 476 to 500 of 12,939 assets
Previous
Page 20 of 518
Next